ClearPoint Neuro, Inc. (CLPT:NASDAQ) closed at $8.48 on November 13, 2026, down 0.12% on the day. The stock trades 56.8% below its 52-week high of $19.63 and 2.5% above its 52-week low of $8.27. Over the past year, it lost 45.0%. ClearPoint Neuro, Inc. is part of the Health Care sector.
In 252 trading sessions since November 13, 2025, CLPT closed higher on 119 days (47%). Its best day was June 17, 2026 (+26.01%) and its worst was September 29, 2026 (-23.12%). The stock moved 10% or more in a single session 14 times. It opened at least 5% above the previous day's high 4 times.
MRI Interventions Inc is a medical device company based in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is in commercial use in the United States, is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. The company's products and product candidates include ClearPoint Neuro Intervention System and The ClearTrace Cardiac Intervention System.
Find more stocks like CLPT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.